Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eugene Dula"'
Autor:
Allen D. Seftel, Evan R. Goldfischer, Edward D. Kim, Patrick R. Burns, Eugene Dula, Haoyue Zeigler
Publikováno v:
Journal of Urology. 185:243-248
We evaluated the efficacy onset and safety of tadalafil 2.5 and 5 mg once daily for 14 days compared with placebo in men with erectile dysfunction.In this randomized, double-blind, placebo controlled, parallel group study we randomized 372 men after
Autor:
Flavia Borellini, Natalie Sacks, Dale Ando, Jonathan W. Simons, Walter J. Urba, William G. Nelson, Arthur S. Centeno, Eric J. Small, John Nemunaitis, Catherine Howard, Eugene Dula, Kristen Hege, Minh Nguyen
Publikováno v:
Clinical Cancer Research. 13:3883-3891
Purpose: This trial evaluated the safety, clinical activity, and immunogenicity of an allogeneic cellular immunotherapy in 55 chemotherapy-naïve patients with hormone-refractory prostate cancer (HRPC). The immunotherapy, based on the GVAX platform,
Publikováno v:
European Urology. 39:558-564
To establish the efficacy and safety of a fixed, 3-mg dose of apomorphine SL compared with placebo, and to compare 3 mg with 4 mg apomorphine SL in patients with erectile dysfunction.This randomized, double-blind, crossover study included 296 heteros
Publikováno v:
Urology. 56:130-135
Objectives. A sublingual (SL) formulation of apomorphine has been developed and found effective in penile erectile dysfunction (ED). This study assessed the efficacy and safety of several doses of apomorphine SL in a dose-optimization schedule compar
Publikováno v:
Pain practice : the official journal of World Institute of Pain. 15(2)
Objective The primary objective of this study was to compare the effects of pregabalin and placebo on sperm concentration in healthy male subjects. Changes in follicle-stimulating hormone (FSH), testosterone, sperm motility, semen volume, and sperm m
Publikováno v:
The Journal of urology. 179(3)
Phosphodiesterase type 5 inhibitors are the first choice therapy in the treatment of erectile dysfunction. Many men in their reproductive years are now using phosphodiesterase type 5 inhibitors. The purpose of this study was to determine the effects
Autor:
Gary E. Leach, Eugene Dula
Publikováno v:
Urology. 37:311-313
This report presents 7 patients with confirmed cases of multiple sclerosis (MS) in whom the diagnosis of MS was first suspected by the urologist. Review of these 7 cases identifies three factors that increased the suspicion of MS at the time of urolo